Is it possible to reduce PCI costs without compromising safety?

Courtesy of Dr. Carlos Fava.

reduce PCI costs without compromising safetyHealth system costs have increased significantly and there have been attempts to reduce it without compromising the quality of PCI outcomes. The benefits of the transradial approach combined with same day discharge could help reach this goal.

 

This study included 279,987 MEDICARE PCI procedures where costs were analyzed. Cases were divided in 4 groups according to access site and discharge:

  • transradial approach and same day discharge, with 3,424 patients (1.2%)
  • transfemoral approach and same day discharge, 11,388 patients (4.1%)
  • transradial approach and next day discharge, 21,877 (7.8%),
  • transfemoral approach and next day discharge, 243,298 patients (86.9%), which was the overwhelming majority.

 

Transradial patients discharged the same day were younger, men, with lower cardiovascular risk and less comorbidities.

 

After variable adjusting, the transradial approach was associated to lower costs, which reached U$S 916 (CI 95%; U$S 778 to 1,035), as was same day discharge (U$S 3,502; CI 3486 to 3902). The total adjusted cost associated to the transradial approach with same day discharge was U$S 13,389 (CI 95%: 13,161 to 13.607), while the transfemoral approach with next day discharge cost U$S 17,076 (CI 95%: 16,999 to 17,147), with an absolute difference of U$S 3,689 (CI 95%: 3486 to 3905; p=<0.0001).

 

In-hospital evolution, bleeding, transfusion needs, vascular complications and hospitalization days were lower with the transradial approach.

 

Conclusion

Among patients who benefit from MEDICARE, the combination of the transradial approach with same day discharge was independently associated with less complications and lower in hospital costs. These findings have important implications in the current practice of PCI, since they improve costs and results.

 

Editorial Comment

This analysis shows it is possible to reduce costs and hospitalization days in selected patients.

 

As we know, the transradial approach has an important learning curve and we should also implement a hospital system to facilitate patient selection for same day discharge.

 

As interventionists, when it comes to cost reduction, it is essential to maintain the safety and quality of outcomes, and to remain cautious when deciding patient discharge.

 

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

 

Original Title: Cost Associated with Access Site and Same-Day discharge Among Medicare Beneficiaries Undergoing Percutaneous Coronary Intervention. An Evaluation of the Current Percutaneous Coronary Intervention care pathways in the United States.

Reference: Amit P Amin et al. JACC Cardiovasc Interv. 2017 Feb 27;10(4):342-351.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...